Cancer Cachexia Market, By Therapeutics (Progestogens, Corticosteroids and Combination Therapy), By Mechanism of Action, By Application, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
REPORT HIGHLIGHT
Cancer Cachexia Market size was valued at USD 3,228.32 Million in 2023, expanding at a CAGR of 5.90% from 2024 to 2032.
Cancer cachexia presents as a multifaceted metabolic syndrome frequently observed in patients with advanced stages of malignancy. Characterized by involuntary weight loss, skeletal muscle wasting, fatigue, and anorexia, this syndrome transcends the limitations of inadequate dietary intake. Underlying mechanisms encompass systemic inflammation, metabolic aberrations, and the host\'s response to tumor-derived factors. Despite advancements in oncological therapies, cancer cachexia remains a formidable challenge, significantly impacting both the treatment outcomes and quality of life for affected individuals.
Cancer Cachexia Market- Market Dynamics
Rising cancer burden to propel market demand
The global cancer burden is rising, necessitating the modification of cancer therapies according to national and regional priorities. According to the (IARC) International Agency for Research on Cancer in December 2020, 1 in 5 people globally will develop cancer during their lifetime, with 1 in 11 women and 1 in 8 men dying from the disease. Data from the WHO, published in February 2022, indicates that approximately 400,000 children develop cancer annually, with the most common types varying by country. For instance, cervical cancer is the most prevalent in 23 countries. The increasing global cancer burden also raises the prevalence of cancer cachexia, characterized by negative protein and energy balance, systemic inflammation, and involuntary loss of lean body mass. The growing prevalence of cancer cachexia, and cancer along with increased investment in R&D for novel cancer cachexia treatments, are major factors driving market growth.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL CANCER CACHEXIA MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHT
Aeterna Zentaris
Aphios Corporation
Bristol-Myers Squibb Company
Pfizer Inc.
Helsinn Group
Merck KGaA
Artelo Biosciences Inc.
NGM Biopharmaceuticals
Aveo Oncology
Aavogen Inc.
Green Cross Wellbeing Corporation
Cannabics Pharmaceuticals Inc.
TCI Peptide Therapeutics
Fresenius Kabi
Tetra Bio-Pharma
Actimed Therapeutics
Others
GLOBAL CANCER CACHEXIA MARKET, BY THERAPEUTICS - MARKET ANALYSIS, 2019 - 2032
Progestogens
Corticosteroids
Combination Therapy
Other Therapeutics
GLOBAL CANCER CACHEXIA MARKET, BY MECHANISM OF ACTION- MARKET ANALYSIS, 2019 - 2032
Appetite Stimulators
Weight Loss Stabilizers
GLOBAL CANCER CACHEXIA MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
GLOBAL CANCER CACHEXIA MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032
North America
o The U.S.
o Canada
Europe
o Germany
o France
o Italy
o Spain
o United Kingdom
o Russia
o Netherlands
o Sweden
o Poland
o Rest of Europe
Asia Pacific
o India
o China
o South Korea
o Japan
o Australia
o Thailand
o Indonesia
o Philippines
o Rest of APAC
Latin America
o Brazil
o Mexico
o Argentina
o Colombia
o Rest of LATAM
The Middle East and Africa
o Saudi Arabia
o United Arab Emirates
o Israel
o Turkey
o Algeria
o Egypt
o Rest of MEA
TABLE OF CONTENT
1. Cancer Cachexia Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Cancer Cachexia Market Snippet by Therapeutics
2.1.2. Cancer Cachexia Market Snippet by Mechanism of Action
2.1.3. Cancer Cachexia Market Snippet by Application
2.1.4. Cancer Cachexia Market Snippet by Country
2.1.5. Cancer Cachexia Market Snippet by Region
2.2. Competitive Insights
3. Cancer Cachexia Key Market Trends
3.1. Cancer Cachexia Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Cancer Cachexia Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Cancer Cachexia Market Opportunities
3.4. Cancer Cachexia Market Future Trends
4. Cancer Cachexia Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Cancer Cachexia Market: COVID-19 Impact Analysis
5.1. Pre-COVID-19 Impact Analysis
5.2. Post-COVID-19 Impact Analysis
5.2.1. Top Performing Segments
5.2.2. Marginal Growth Segments
5.2.3. Top Looser Segments
5.2.4. Marginal Loss Segments
6. Cancer Cachexia Market Landscape
6.1. Cancer Cachexia Market Share Analysis, 2023
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Cancer Cachexia Market – By Therapeutics
7.1. Overview
7.1.1. Segment Share Analysis, By Therapeutics, 2023 & 2032 (%)
7.1.2. Progestogens
7.1.3. Corticosteroids
7.1.4. Combination Therapy
7.1.5. Other Therapeutics
8. Cancer Cachexia Market – By Mechanism of Action
8.1. Overview
8.1.1. Segment Share Analysis, By Mechanism of Action, 2023 & 2032 (%)
8.1.2. Appetite Stimulators
8.1.3. Weight Loss Stabilizers
9. Cancer Cachexia Market – By Application
9.1. Overview
9.1.1. Segment Share Analysis, By Application, 2023 & 2032 (%)
9.1.2. Hospital Pharmacy
9.1.3. Retail Pharmacy
9.1.4. Online Pharmacy
10. Cancer Cachexia Market– By Geography
10.1. Introduction
10.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
10.2. North America
10.2.1. Overview
10.2.2. Cancer Cachexia Key Manufacturers in North America
10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.2.4. North America Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
10.2.5. North America Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
10.2.6. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.2.7. U.S.
10.2.7.1. Overview
10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.2.7.3. U.S. Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
10.2.7.4. U.S. Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
10.2.7.5. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.2.8. Canada
10.2.8.1. Overview
10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.2.8.3. Canada Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
10.2.8.4. Canada Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
10.2.8.5. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3. Europe
10.3.1. Overview
10.3.2. Cancer Cachexia Key Manufacturers in Europe
10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.3.4. Europe Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
10.3.5. Europe Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
10.3.6. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.7. Germany
10.3.7.1. Overview
10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.7.3. Germany Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
10.3.7.4. Germany Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
10.3.7.5. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.8. Italy
10.3.8.1. Overview
10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.8.3. Italy Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
10.3.8.4. Italy Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
10.3.8.5. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.9. United Kingdom
10.3.9.1. Overview
10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.9.3. United Kingdom Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
10.3.9.4. United Kingdom Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
10.3.9.5. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.10. France
10.3.10.1. Overview
10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.10.3. France Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
10.3.10.4. France Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
10.3.10.5. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.11. Russia
10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.11.2. Russia Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
10.3.11.3. Russia Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
10.3.11.4. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.12. Netherlands
10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.12.2. Netherlands Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
10.3.12.3. Netherlands Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
10.3.12.4. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.13. Sweden
10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.13.2. Sweden Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
10.3.13.3. Sweden Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
10.3.13.4. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.14. Poland
10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.14.2. Poland Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
10.3.14.3. Poland Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
10.3.14.4. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.15. Rest of Europe
10.3.15.1. Overview
10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.15.3. Rest of the Europe Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
10.3.15.4. Rest of the Europe Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
10.3.15.5. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4. Asia Pacific (APAC)
10.4.1. Overview
10.4.2. Cancer Cachexia Key Manufacturers in Asia Pacific
10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.4.4. Asia Pacific Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
10.4.5. Asia Pacific Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
10.4.6. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.7. India
10.4.7.1. Overview
10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.7.3. India Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
10.4.7.4. India Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
10.4.7.5. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.8. China
10.4.8.1. Overview
10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.8.3. China Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
10.4.8.4. China Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
10.4.8.5. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.9. Japan
10.4.9.1. Overview
10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.9.3. Japan Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
10.4.9.4. Japan Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
10.4.9.5. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.10. South Korea
10.4.10.1. Overview
10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.10.3. South Korea Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
10.4.10.4. South Korea Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
10.4.10.5. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.11. Australia
10.4.11.1. Overview
10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.11.3. Australia Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
10.4.11.4. Australia Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
10.4.11.5. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.12. Thailand
10.4.12.1. Overview
10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.12.3. Thailand Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
10.4.12.4. Thailand Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
10.4.12.5. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.13. Indonesia
10.4.13.1. Overview
10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.13.3. Indonesia Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
10.4.13.4. Indonesia Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
10.4.13.5. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.14. Philippines
10.4.14.1. Overview
10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.14.3. Philippines Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
10.4.14.4. Philippines Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
10.4.14.5. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.15. Rest of APAC
10.4.15.1. Overview
10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.15.3. Rest of APAC Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
10.4.15.4. Rest of APAC Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
10.4.15.5. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.5. Latin America
10.5.1. Overview
10.5.2. Cancer Cachexia Key Manufacturers in Latin America
10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.5.4. Latin America Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
10.5.5. Latin America Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
10.5.6. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.5.7. Brazil
10.5.7.1. Overview
10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.7.3. Brazil Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
10.5.7.4. Brazil Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
10.5.7.5. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.5.8. Mexico
10.5.8.1. Overview
10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.8.3. Mexico Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
10.5.8.4. Mexico Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
10.5.8.5. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.5.9. Argentina
10.5.9.1. Overview
10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.9.3. Argentina Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
10.5.9.4. Argentina Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
10.5.9.5. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.5.10. Colombia
10.5.10.1. Overview
10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.10.3. Colombia Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
10.5.10.4. Colombia Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
10.5.10.5. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.5.11. Rest of LATAM
10.5.11.1. Overview
10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.11.3. Rest of LATAM Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
10.5.11.4. Rest of LATAM Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
10.5.11.5. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.6. Middle East and Africa
10.6.1. Overview
10.6.2. Cancer Cachexia Key Manufacturers in Middle East and Africa
10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.6.4. Middle East and Africa Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
10.6.5. Middle East and Africa Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
10.6.6. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.6.7. Saudi Arabia
10.6.7.1. Overview
10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.7.3. Saudi Arabia Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
10.6.7.4. Saudi Arabia Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
10.6.7.5. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.6.8. United Arab Emirates
10.6.8.1. Overview
10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.8.3. United Arab Emirates Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
10.6.8.4. United Arab Emirates Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
10.6.8.5. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.6.9. Israel
10.6.9.1. Overview
10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.9.3. Israel Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
10.6.9.4. Israel Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
10.6.9.5. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.6.10. Turkey
10.6.10.1. Overview
10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.10.3. Turkey Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
10.6.10.4. Turkey Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
10.6.10.5. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.6.11. Algeria
10.6.11.1. Overview
10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.11.3. Algeria Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
10.6.11.4. Algeria Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
10.6.11.5. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.6.12. Egypt
10.6.12.1. Overview
10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.12.3. Egypt Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
10.6.12.4. Egypt Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
10.6.12.5. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.6.13. Rest of MEA
10.6.13.1. Overview
10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.13.3. Rest of MEA Market Size and Forecast, By Therapeutics, 2019 - 2032 (US$ Million)
10.6.13.4. Rest of MEA Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
10.6.13.5. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11. Key Vendor Analysis- Cancer Cachexia Industry
11.1. Competitive Dashboard
11.2. Company Profiles
11.2.1. Aeterna Zentaris
11.2.2. Aphios Corporation
11.2.3. Bristol-Myers Squibb Company
11.2.4. Pfizer Inc.
11.2.5. Helsinn Group
11.2.6. Merck KGaA
11.2.7. Artelo Biosciences Inc.
11.2.8. NGM Biopharmaceuticals
11.2.9. Aveo Oncology
11.2.10. Aavogen Inc.
11.2.11. Green Cross Wellbeing Corporation
11.2.12. Cannabics Pharmaceuticals Inc.
11.2.13. TCI Peptide Therapeutics
11.2.14. Fresenius Kabi
11.2.15. Tetra Bio-Pharma
11.2.16. Actimed Therapeutics
11.2.17. Others
12. 360 Degree Analyst View
13. Appendix
13.1. Research Methodology
13.2. References
13.3. Abbreviations
13.4. Disclaimer
13.5. Contact Us
